dc.contributor.author | Allwell-Brown, Gbemisola | |
dc.contributor.author | Hussain-Alkhateeb, Laith | |
dc.contributor.author | Kitutu, Freddy Eric | |
dc.contributor.author | Strömdahl, Susanne | |
dc.contributor.author | Mårtensson, Andreas | |
dc.contributor.author | JohanssonAllwell-Brown, Emily White | |
dc.date.accessioned | 2022-02-05T09:07:00Z | |
dc.date.available | 2022-02-05T09:07:00Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Allwell-Brown, G., Hussain-Alkhateeb, L., Kitutu, F. E., Strömdahl, S., Mårtensson, A., & Johansson, E. W. (2020). Trends in reported antibiotic use among children under 5 years of age with fever, diarrhoea, or cough with fast or difficult breathing across low-income and middle-income countries in 2005–17: a systematic analysis of 132 national surveys from 73 countries. The Lancet Global Health, 8(6), e799-e807. | en_US |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S2214109X20300796 | |
dc.identifier.uri | https://nru.uncst.go.ug/xmlui/handle/123456789/1930 | |
dc.description.abstract | Global assessments of antibiotic consumption have relied on pharmaceutical sales data that do not
measure individual-level use, and are often unreliable or unavailable for low-income and middle-income countries
(LMICs). To help fill this evidence gap, we compiled data from national surveys in LMICs in 2005–17 reporting
antibiotic use for sick children under the age of 5 years.
Methods Based on 132 Demographic and Health Surveys and Multiple Indicator Cluster Surveys from 73 LMICs, we
analysed trends in reported antibiotic use among children under 5 years of age with fever, diarrhoea, or cough with
fast or difficult breathing by WHO region, World Bank income classification, and symptom complaint. A logit
transformation was used to estimate the outcome using a linear Bayesian regression model. The model included
country-level socioeconomic, disease incidence, and health system covariates to generate estimates for country-years
with missing values.
Findings Across LMICs, reported antibiotic use among sick children under 5 years of age increased from 36·8%
(uncertainty interval [UI] 28·8–44·7) in 2005 to 43·1% (33·2–50·5) in 2017. Low-income countries had the greatest
relative increase; in these countries, reported antibiotic use for sick children under 5 years of age rose 34% during the
study period, from 29·6% (21·2–41·1) in 2005 to 39·5% (32·9–47·6) in 2017, although it remained the lowest of any
income group throughout the study period.
Interpretation We found a limited but steady increase in reported antibiotic use for sick children under 5 years of age
across LMICs in 2005–17, although overlapping UIs complicate interpretation. The increase was largely driven by
gains in low-income countries. Our study expands the evidence base from LMICs, where strengthening antibiotic
consumption and resistance surveillance is a global health priority. | en_US |
dc.language.iso | en | en_US |
dc.publisher | The Lancet Global Health | en_US |
dc.subject | Antibiotic use | en_US |
dc.subject | Fever | en_US |
dc.subject | Diarrhoea | en_US |
dc.subject | Cough | en_US |
dc.subject | Low-income and middle-income countries | en_US |
dc.subject | National surveys | en_US |
dc.title | Trends in reported antibiotic use among children under 5 years of age with fever, diarrhoea, or cough with fast or difficult breathing across low-income and middle-income countries in 2005–17: a systematic analysis of 132 national surveys from 73 countries | en_US |
dc.type | Article | en_US |